Multidrug-resistant Candida auris is an urgent antimicrobial resistance threat and the key method of prevention is strict adherence to infection control measures.
The FDA has approved Xenleta (lefamulin; Nabriva Therapeutics) for the treatment of adults with community-acquired bacterial pneumonia (CABP) caused by the following susceptible microorganisms: Streptococcus pneumoniae, Staphylococcus aureus (methicillin-susceptible isolates), Haemophilus influenzae, Legionella pneumophila, Mycoplasma pneumoniae, and Chlamydophila pneumoniae.
Represcription rate at 28 days only 4.1 percent from 2011 to 2015; slight increase seen for men over time
The use of levofloxacin as prophylaxis for the prevention of neutropenic fever and bloodstream infections was associated with less disruption of the gut microbiome in patients with hematologic malignancy.
The FDA has approved pretomanid tablets in combination with bedaquiline and linezolid for the treatment of adults with pulmonary XDR, treatment-intolerant or nonresponsive MDR tuberculosis.
Investigators evaluated changes in the microbiology of osteomyelitis over a 10-year period, including infection with multidrug-resistant bacteria and susceptibility of antimicrobial regimens.
The researchers aimed to describe the incidence of bacteremia in patients with SLE, and identify risk factors.
The FDA has approved Sirturo (bedaquiline; Janssen) for use in pediatric patients aged 12 to less than 18 years for MDR-TB.
New drugs cured two Ebola patients in Congo, showing that people can recover from the highly lethal disease if it is diagnosed and treated early.
Investigators performed a comprehensive review on the prevalence of nonprescription antibiotic use in the United States and analyzed the factors that influence it.
All forms of rifampin-resistant tuberculosis may be positively associated with HIV and increased mortality.
Overuse of broad-spectrum antibiotics is associated with increased mortality and other poor outcomes in adults admitted for community-onset pneumonia.
The first transmission of the Ebola virus in Congo’s major city of Goma was announced.
This is the first study to describe persistent joint pain and stiffness many months after infection with the chikungunya virus.
Since 2013, active surveillance for MRSA reduced, monitoring of cleaning effectiveness increased
Nonprescription antibiotic use appears to be prevalent in the United States.
The FDA has approved Recarbrio for the treatment of adult patients aged 18 years and older with complicated UTI.
In a review update, XpertMTB/RIF was found to be sensitive and specific for diagnosing pulmonary TB and rifampicin resistance which is consistent with the last review completed in 2014.
The first case of Ebola in the city of Goma has been confirmed, Democratic Republic of Congo officials said Sunday.
Short-term use of doxycycline in pediatric patients younger than 8 years old does not appear to discolor teeth or weaken tooth enamel.